LONDON (Alliance News) - The all-share merger between Vectura Group PLC and Skyepharma PLC was set to be completed Friday, as the scheme of arrangement regarding the terms of the merger has become effective.
Skyepharma's shares will be cancelled from Friday, and shares in the merged entity will be admitted to trading on the London Stock Exchange's Main Market on Friday morning.
The merger was cleared by the UK Competition & Markets Authority in May.
Following the completion of the takeover of Skyepharma, Vectura Chief Financial Officer Andrew Oakley will leave the company, to be succeeded by Andrew Derodra.
By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews
Copyright 2016 Alliance News Limited. All Rights Reserved.
